Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. We have a new way of making ...

Mysuru: Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common issue among elderly men in India, often ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in ... J&J said Javelin demonstrated a procedure success rate of 99%, with a major ...

The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S. Coronary Artery Disease (CAD) is the most common ...

"Patients with post-lithotripsy residual fragments are more likely to have complications, emergency department visits, or repeat procedures, yet they have no reliable non-invasive option aside ...

Abbott announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment ...